Related Experiment Video
Updated: Aug 24, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
Sarah de Ferranti1, Nader Rifai
1Department of Cardiology, Children's Hospital and Harvard Medical School, Boston, MA, USA.
Insights
C-reactive protein (CRP) is linked to cardiovascular disease (CVD) risk, even in individuals without high cholesterol. Reliable CRP testing could aid in predicting outcomes and screening for CVD.
Area of Science:
- Cardiovascular Medicine
- Biomarkers
- Preventive Cardiology
Background:
- Coronary vascular disease (CVD) affects many, yet a significant portion of patients have normal cholesterol.
- Elevated C-reactive protein (CRP) is linked to CVD in both acute and apparently healthy individuals.
Purpose of the Study:
- To review the association between CRP and CVD.
- To examine CRP's relationship with traditional CVD risk factors (smoking, hypertension, cholesterol, obesity).
- To investigate the effect of CVD medications on CRP levels.
Main Methods:
- Literature review on CRP and CVD.
- Analysis of CRP in relation to established risk factors.
- Examination of medication effects on CRP.
Main Results:
- CRP levels correlate with CVD risk across various patient groups, including those with a history of acute coronary disease, stable angina, and no prior CVD diagnosis.
- CRP independently predicts CVD risk, irrespective of cholesterol levels (hyperlipidemia).
Conclusions:
- Reliable CRP assays could enhance prediction of short- and long-term cardiovascular outcomes.
- CRP may become a valuable screening tool for CVD, similar to lipid profiles.
- Future research may lead to CRP influencing treatment and preventive strategies for CVD.
Background:
Coronary vascular disease (CVD) has a high prevalence in the United States, yet 40-50% of those with that diagnosis have normal or mildly increased cholesterol levels. Increased C-reactive protein (CRP) has been associated with CVD, in those presenting after an acute coronary event, and also in apparently healthy individuals.
Methods:
We reviewed the literature on this association, and on the relationship between CRP and traditional CVD risk factors including smoking, hypertension, cholesterol and obesity. Also examined is the effect of various medications used in patients with CVD on CRP concentrations.
Results:
CRP correlates with risk of CVD in patients who have a history of acute coronary disease, stable angina, and in those who have never been diagnosed with CVD. CRP imparts risk that is independent of hyperlipidemia.
Conclusion:
Once commercially available CRP assays are shown to be reliable, CRP may help predict short- and long-term cardiovascular outcomes and may have a role in CVD screening analogous to that of lipid. In the future CRP may modify treatment and preventive therapies.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

